🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the firms withheld alleged dangers that the pain reliever created to children's brain development.

The court filing follows thirty days after President Donald Trump advocated an unsubstantiated connection between taking acetaminophen - also known as acetaminophen - while pregnant and autism in children.

The attorney general is filing suit against Johnson & Johnson, which previously sold the drug, the only pain reliever recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he stated they "deceived the public by profiting off of discomfort and marketing drugs ignoring the dangers."

Kenvue states there is insufficient reliable data connecting acetaminophen to autism.

"These corporations deceived for years, intentionally threatening numerous people to line their pockets," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the welfare of American women and children."

On its website, the company also said it had "regularly reviewed the pertinent research and there is no credible data that indicates a proven link between taking acetaminophen and autism."

Organizations acting on behalf of physicians and healthcare providers concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and fever, which can present serious health risks if ignored.

"In over twenty years of investigation on the utilization of acetaminophen in gestation, zero credible investigations has conclusively proven that the use of acetaminophen in any trimester of pregnancy results in brain development issues in young ones," the group stated.

The court filing cites recent announcements from the former administration in asserting the drug is potentially dangerous.

Recently, the former president raised alarms from medical authorities when he advised expectant mothers to "struggle intensely" not to consume Tylenol when sick.

Federal regulators then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in spring to conduct "extensive scientific investigation" that would establish the origin of autism in a matter of months.

But specialists warned that finding a unique factor of autism - thought by researchers to be the outcome of a complicated interplay of inherited and external influences - would be difficult.

Autism spectrum disorder is a form of permanent neurological difference and disability that affects how persons experience and engage with the environment, and is recognized using doctors' observations.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "destroy any marketing or advertising" that states acetaminophen is secure for expectant mothers.

The court case echoes the complaints of a assembly of parents of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

The court rejected the legal action, declaring investigations from the plaintiffs' authorities was lacking definitive proof.